G Gypebraxranny Guest Aug 15, 2008 #1 In the function missive, the FDA up to date the back (Astellas) that it has completed its reassess of the Kynapid NDA and that the relevancy is approvable. former to in view of approval
In the function missive, the FDA up to date the back (Astellas) that it has completed its reassess of the Kynapid NDA and that the relevancy is approvable. former to in view of approval